Skip to content

A Pilot RCT on the Management of Term Prelabour Rupture of Membranes

Active vs Expectant Management and Routine vs Only-when-necessary Vaginal Examinations During Labour for Prelabour Rupture of Membranes at Term, a Pilot RCT Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02872883
Enrollment
120
Registered
2016-08-19
Start date
2016-11-30
Completion date
2017-11-30
Last updated
2016-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prelabour Rupture of Membranes at Term

Keywords

Prelabour rupture of membranes, term pregnancy, management, vaginal examination, induction of labour, expectant management

Brief summary

This is a pilot study that will eventually result in a main randomised controlled trial that will look at what management is associated with a higher rate of normal birth and a lower rate of chorioamnionitis (maternal infection) when women break their waters but labour does not start. Spontaneous rupture of the membranes (when the waters break) at term (37-42 weeks gestation) is a physiological event that happens during labour. However, according to Gunn et al. (1970) in 8-10 % of the cases the membranes rupture before labour starts. The time between the rupture and the onset of labour is called latent phase and time wise is variable. Studies have showed no statistically significant differences in terms of neonatal infection or chorioamnionitis when the investigators induce labour with prostaglandins compared to when labour starts spontaneously (Hannah et al 1996). Seaward et al. (1997) noted a number of confounding factors that might relate to the incidence of chorioamnionitis (maternal infection), the strongest predictor was having more than 8 vaginal examinations since the rupture of membranes and before delivery which was a stronger predictor than the duration of the latent phase. It is thought that by reducing the number of internal examinations, chorioamnionitis may be reduced, and hence neonatal infection may also be reduced. The main RCT will compare clinical outcomes and maternal satisfaction when women consent to be randomized to four groups: (1) Active management and routine internal examinations during labour, (2) Active management and reduced internal examinations, (3) Expectant management and routine internal examinations, (4) Expectant management and reduced internal examinations. This application seeks ethics approval for the pilot phase to ensure that a definitive study can be undertaken appropriately. It is important to test that all the components work well individually and as a whole, to estimate sample size and ultimately to test the integrity of the research protocol before embarking on the main trial.

Interventions

PROCEDUREMinimal Vaginal examinations (only when necessary)
PROCEDUREActive management
PROCEDURERoutine vaginal examinations

Sponsors

Lancashire Care NHS Foundation Trust
CollaboratorNETWORK
University of Central Lancashire
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Prelabour rupture of membranes (confirmed) * Term pregnancy - from 37+0 till 41+2 weeks gestation (both inclusive) * Normal/Low risk pregnancy * Singleton, cephalic pregnancy * No known current infectious diseases * Aged 18-45 years old * Understands English and is able to read and write in English * Agree for their placentas to be sent to histology if clinical signs of infection * Not taking part in other clinical research at present * Consent to take part

Exclusion criteria

* Pregnancy of 36+6 or less or 41+3 or more weeks gestation * Breech or oblique presentation * Twin or multiple pregnancy * Previous caesarean section * Meconium stained liquor * Pre-eclampsia * Diabetes * Known to be colonised by Group B streptococcus * Current infections: HIV, Hepatitis B, Herpes * Doesn't give consent for the placenta to be sent to histology if clinical signs of infection * Not able to understand, read or write in English * Currently taking part in other clinical research

Design outcomes

Primary

MeasureTime frame
Percentage of eligible women who agree to take part in the study12 months during pilot stage

Secondary

MeasureTime frameDescription
Percentage of participants who stay in the allocation arm12 months during pilot stage
Percentage of participants who find the interventions acceptableThe questionnaire will be completed by the participants between 4-8 weeks after giving birthAcceptability of the interventions to participants as measured by the study questionnaire

Countries

United Kingdom

Contacts

Primary ContactLucia Ramirez-Montesinos, MSc BSc
Lramirez-montesinos@uclan.ac.uk00447897236172

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026